UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale

BMJ open, 2022-02, Vol.12 (2), p.e050635-e050635

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland

Diabetes therapy, 2019-04, Vol.10 (2), p.563-574

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

Diabetes technology & therapeutics, 2019-03, Vol.21 (3), p.110

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of TNF-α blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system

Dermatologic therapy, 2010-01, Vol.23 (s1), p.S7-S13

2010

Link zum Volltext

Verfügbarkeit prüfen

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

Diabetes, obesity & metabolism, 2016-05, Vol.18 (5), p.500-507

2016

Link zum Volltext

Verfügbarkeit prüfen

904-P: 12-Month Treatment Satisfaction (TS) and Fear of Hypoglycemia (FoH) Outcomes in the ADAPT Study—A Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System (AHCL) to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece

Diabetes technology & therapeutics, 2022-05, Vol.24 (5), p.316

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK

Journal of medical economics, 2021-01, Vol.24 (1), p.883-890

2021

Link zum Volltext

Verfügbarkeit prüfen

Short-term cost analysis of complications related to glycated hemoglobin in patients with type 1 diabetes in the Italian setting

Acta diabetologica, 2016-04, Vol.53 (2), p.199-204

2016

Link zum Volltext

Verfügbarkeit prüfen

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

The lancet. Diabetes & endocrinology, 2022-10, Vol.10 (10), p.720-731

2022

Link zum Volltext

Verfügbarkeit prüfen

Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes

Diabetes, obesity & metabolism, 2023-11, Vol.25 (11), p.3212-3222

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands

Advances in therapy, 2022-04, Vol.39 (4), p.1844-1856

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France

Diabetes technology & therapeutics, 2016-02, Vol.18 (2), p.75

2016

Link zum Volltext

Verfügbarkeit prüfen

Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands

Advances in therapy, 2023-05, Vol.40 (5), p.2545-2548

2023

Link zum Volltext

Verfügbarkeit prüfen

Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring

Journal of diabetes science and technology, 2023-03, p.19322968231161320-19322968231161320

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus‐basal insulin regimens: An analysis from the OpT2mise randomized trial

Diabetes, obesity & metabolism, 2017-10, Vol.19 (10), p.1490-1494

2017

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive assessment of coronary flow reserve and ADMA levels: a case–control study of early rheumatoid arthritis patients

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.834-839

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey

Diabetes technology & therapeutics, 2019-12, Vol.21 (12), p.727

2019

Link zum Volltext

Verfügbarkeit prüfen

Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes

Diabetes technology & therapeutics, 2018-11, Vol.20 (11), p.758

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective

Journal of medical economics, 2016-03, Vol.19 (3), p.236-242

2016

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus‐basal insulin regimens: A n analysis from the OpT2mise randomized trial

Diabetes, obesity & metabolism, 2017-10, Vol.19 (10), p.1490-1494

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

Diabetes therapy, 2017-10, Vol.8 (5), p.1015-1030

2017

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

Arthritis research & therapy, 2006-01, Vol.8 (1), p.R3-R3

2006

Link zum Volltext

Verfügbarkeit prüfen

Notification of undesirable effects of cosmetics and toiletries

Pharmacological research, 2009-02, Vol.59 (2), p.101-106

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands

ClinicoEconomics and outcomes research, 2019, Vol.11, p.73-82

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(31)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Adult
(18)
Diabetes
(18)
Female
(18)
Male
(18)
Cost-Benefit Analysis
(17)
Endocrinology & Metabolism
(14)
Middle Aged
(14)
Insulin
(12)
Cost-Effectiveness
(11)
Diabetes Mellitus, Type 1 - Drug Therapy
(11)
Hypoglycemia
(10)
Aged
(8)
Blood Glucose Self-Monitoring
(8)
Glucose
(8)
Glucose Monitoring
(8)
Glycated Hemoglobin A - Analysis
(8)
Insulin Infusion Systems
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale

Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

Cost-effectiveness analysis of TNF-α blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

904-P: 12-Month Treatment Satisfaction (TS) and Fear of Hypoglycemia (FoH) Outcomes in the ADAPT Study—A Randomized Controlled Trial Comparing an Advanced Hybrid Closed-Loop System (AHCL) to Multiple Daily Injections (MDI) with Intermittently Scanned CGM (isCGM)

Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece

Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK

Short-term cost analysis of complications related to glycated hemoglobin in patients with type 1 diabetes in the Italian setting

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes

Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands

Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France

Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands

Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus‐basal insulin regimens: An analysis from the OpT2mise randomized trial

Non-invasive assessment of coronary flow reserve and ADMA levels: a case–control study of early rheumatoid arthritis patients

Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey

Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus‐basal insulin regimens: A n analysis from the OpT2mise randomized trial

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

Notification of undesirable effects of cosmetics and toiletries

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands

Suchergebnisse filtern